Page 1
December 18 (Saturday)
Venue Channel 1 Channel 2 Channel 3 Channel 4
09:00
10:30
TSOC Consensus on Pharmacological Treatment for HF
(I) (P.1)
Cross Discipline Session
(I) (P.3)
Pediatric Cardiology (P.5)
TSOC 心臟血管專科訓練認定基準討論會
(P.7)
10:30 11:00 Healthy Break
11:00
12:30
TSOC Consensus on Pharmacological Treatment for HF
(II) (P.2)
Cross Discipline Session
(II) (P.4)
Consensus in TAVR Indication
(P.6)
12:40
14:00
Luncheon Symposium
[AstraZeneca] (P.24)
Luncheon Symposium
[Boehringer-Ingelheim] (P.25)
Luncheon Symposium
[Daiichi Sankyo] (P.26)
Luncheon Symposium
[Bayer] (P.27)
14:00
15:30
TSOC CCS Guidelines: Diagnosis
(I) (P.8)
Update on AF Management &
Therapy (P.10)
Cardiovascular Surgery (P.12)
善用新興工具 跨越研究障礙
(P.14)
15:30 16:00
Healthy Break
16:00
17:30
TSOC CCS Guidelines: Management
(II) (P.9)
Advance on Cardiac Pacing (P.11)
Joint Session on Pediatric and CV
Surgery (P.13)
MOST-TSOC Joint Symposium
(P.15)
17:40
19:00
Evening Symposium [Novartis]
(P.28)
Evening Symposium
[Pfizer] (P.29)
Evening Symposium
[Takeda] (P.30)
Evening Symposium
[Novo Nordisk] (P.31)
December 19 (Sunday)
Venue Channel 1 Channel 2 Channel 3 Channel 4
09:00
10:30
Heart Failure (I)
(P.16)
Interventional Cardiology
(I) (P.18)
Cardiac Imaging (I)
(P.20)
Updated Report of the TAIPAN
Registry (P.22)
10:30 11:00
Healthy Break
11:00
12:30
Heart Failure: (II)
(P.17)
Interventional Cardiology
(II) (P.19)
Cardiac Imaging (II)
(P.21)
Hypertension (P.23)
12:40
14:00
Luncheon Symposium
[Pfizer] (P.32)
Luncheon Symposium [Organon]
(P.33)
Luncheon Symposium [Menarini]
(P.34)
Luncheon Symposium
[AstraZeneca] (P.35)
Page 2
1
12月18日〈星期六〉09:00-10:30 SATURDAY, DECEMBER 18, 2021
Channel 1
TSOC CONSENSUS ON PHARMACOLOGICAL THERAPY FOR
HEART FAILURE (I)
09:00 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 葉宏一(Hung-I Yeh)
09:05 Classification of HF ............................................................................. 吳彥雯
(Yen-Wen Wu)
Chair: 褚柏顯(Pao-Hsien Chu)
09:20 blocker in HFrEF ............................................................................. 林宗憲
(Tsung-Hsien Lin)
Chair: 陳文鍾(Wen-Jone Chen)
09:35 ACEI/ARB in HFrEF ............................................................................. 吳卓鍇
(Cho-Kai Wu)
Chair: 謝宜璋(I-Chang Hsieh)
09:50 MRA in HFrEF ..................................................................................... 林彥宏
(Yen-Hung Lin)
Chair: 趙庭興(Ting-Hsing Chao)
10:05 Ivabradine in HFrEF ............................................................................. 黃金隆
(Jin-Long Huang)
Chair: 林幸榮(Shing-Jong Lin)
10:20 Panel Discussion
10:25 Closing Remarks ................................................................................. 李啟明
(Chii-Ming Lee)
Page 3
2
12月18日〈星期六〉11:00-12:30 SATURDAY, DECEMBER 18, 2021
Channel 1
TSOC CONSENSUS ON PHARMACOLOGICAL THERAPY FOR
HEART FAILURE (II)
11:00 Opening Remarks ................................................................................ 李啟明
(Chii-Ming Lee)
Chair: 林俊立(Jiunn-Lee Lin)
11:05 Sacubitril/valsartan in HFrEF ................................................................. 翁國昌
(Kwo-Chang Ueng)
Chair: 陳震寰(Chen-Huan Chen)
11:20 SGLT-2 inhibitor in HFrEF ..................................................................... 江晨恩
(Chern-En Chiang)
Chair: 劉秉彥(Ping-Yen Liu)
11:35 Vericiquat in HFrEF .............................................................................. 趙庭興
(Ting-Hsing Chao)
Chair: 王俊傑(Chun-Chieh Wang)
11:50 Expert consensus ................................................................................ 江晨恩
(Chern-En Chiang)
Chair: 李啟明(Chii-Ming Lee)
12:05 Management of HFmrEF and HFpEF ..................................................... 宋思賢
(Shih-Hsien Sung)
Chair: 江晨恩(Chern-En Chiang)
12:20 Panel Discussion
12:25 Closing Remarks ................................................................................. 葉森洲
(San-Jou Yeh)
Page 4
3
12月18日〈星期六〉09:00-10:30 SATURDAY, DECEMBER 18, 2021
Channel 2
CROSS DISCIPLINE SESSION (I)
CARDIO-ONCOLOGY SECTION
09:00 Opening Remarks ................................................................................ 余文鍾
(Wen-Chung Yu)
Chair: 余文鍾(Wen-Chung Yu)
09:05 Approach to Cardiotoxicity with Immunotherapy for Cancer ...................... 張瑋婷
(Wei-Ting Chang)
Chair: 熊佩韋(Pei-Wei Xiong)
09:30 Focus on Radiation-induced Cardiovascular Disease:
The 2021 TASTRO-TSOC Consensus ................................................... 呂隆昇
(Long-Sheng Lu)
Chair: 楊甯貽(Ning-I Yang)
09:55 ACEI/ARB in HFrEF ............................................................................. 吳卓鍇
(Cho-Kai Wu)
Chair: 楊甯貽(Ning-I Yang)
10:20 Panel Discussion
10:25 Closing Remarks ................................................................................. 楊甯貽
(Ning-I Yang)
Page 5
4
12月18日〈星期六〉11:00-12:30 SATURDAY, DECEMBER 18, 2021
Channel 2
CROSS DISCIPLINE SESSION (II)
THE CARDIOLOGIST AT THE TIME OF CORONAVIRUS
11:00 Opening Remarks ................................................................................ 吳彥雯
(Yen-Wen Wu)
Chair: 吳彥雯(Yen-Wen Wu)
11:05 Thrombosis & ACS in COVID-19 and Its Relevant Vaccine:
It’s Possible Mechanism- NET ............................................................... 鄭凱鴻
(Kai-Hung Cheng)
Chair: 吳彥雯(Yen-Wen Wu)
11:30 Managing ACS and HF during COVID-19 Pandemic ............................... 王朝永
(Chao-Yung Wang)
Chair: 莊志明(Jimmy Jyh-Ming Juang)
11:55 Virtual Care and Telemedicine ............................................................. 李任光
(Jen-Kuang Lee)
Chair: 莊志明(Jimmy Jyh-Ming Juang)
12:20 Panel Discussion
12:25 Closing Remarks ................................................................................. 莊志明
(Jimmy Jyh-Ming Juang)
Page 6
5
12月18日〈星期六〉09:00-10:30 SATURDAY, DECEMBER 18, 2021
Channel 3
SYMPOSIUM ON PEDIATRIC CARDIOLOGY
Chairs: 吳美環(Mei-Hwan Wu)、戴任恭(Zen-Kong Dai)
09:00 Epidemiology and Outcomes of Myocarditis in Children ........................... 林明志
(Ming-Chih Lin)
09:15 Diagnosis of Myocarditis in Children ...................................................... 曾偉杰
(Wei-Chieh Tseng)
09:30 Treatment of Pediatric Viral Myocarditis ................................................. 王玠能
(Jieh-Neng Wang)
09:45 An Overviews of mRNA Vaccine Related Myocarditis and
Pericarditis in Adolescents…………. ...................................................... 簡卲如
(Shao-Ju Chien)
10:00 ECG Screening for mRNA Vaccine Related Myocarditis and Pericarditis ... 邱舜南
(Shuenn-Nan Chiu)
10:15 Panel Discussion
Page 7
6
12月18日〈星期六〉11:00-12:30 SATURDAY, DECEMBER 18, 2021
Channel 3
CONSENSUS IN TAVR INDICATION
11:00 Opening Remarks ................................................................................ 殷偉賢
(Wei-Hsian Yin)
Chair: 高憲立(Hsien-Li Kao)
11:03 Comparison between AHA/ACC and ESC Guideline ............................... 鄭正一
(Cheng-I Cheng)
11:13 Q & A
Chair: 張仁平(Jen-Ping Chang)
11:17 The Threshold of Age ........................................................................... 宋思賢
(Shih-Hsien Sung)
11:27 Q & A
Chair: 陳嬰華(Ying-Hwa Chen)
11:31 Bicuspid Aortic Valve and Associated Aortopathy .................................... 蔡峰鈞
(Feng-Chun Tsai)
11:41 Q & A
Chair: 施俊哲(Chun-Che Shih)
11:45 Severe Aortic Stenosis Combined with Complex CAD ............................. 林茂欣
(Mao-Shin Lin)
11:55 Q & A
Chair: 李文領(Wen-Lieng Lee)
11:59 Concomitant Valvular Disease ............................................................... 柯宏彥
(Hung_Yen Ke)
12:03 Q & A
Chair: 康沛倫(Pei-Leun Kang)
12:13 Alternative Access for TAVR vs SAVR .................................................... 李國楨
(Kuo-Chen Lee)
12:23 Q & A
12:27 Closing Remarks ................................................................................. 謝宜璋
(I-Chang Hsieh)
Page 8
7
12月18日〈星期六〉09:00-12:30 SATURDAY, DECEMBER 18, 2021
Channel 4
TSOC 心臟血管專科訓練認定基準討論會
09:00 Opening Remarks ................................................................................ 陳震寰
(Chen-Huan Chen)
Session I. 心臟血管內科
Chair: 鄭景仁(Jing-Ren Jeng)
09:08 Presentation ........................................................................................ 何鴻鋆
(Hung-Chin Ho)
09:38 與談人: 林庭光(Tin-Kwang Lin)、吳彥雯(Yen-Wen Wu)
09:58 Q & A
10:08 Break
Session II. 心臟血管外科
Chair: 施俊哲(Chun-Che Shih)
10:16 Presentation ........................................................................................ 林萍章
(Pyng Jing Lin)
10:46 與談人: 張忠毅(Chung-Yi Chang)、蔡宜廷(Yi-Ting Tsai)、
阮俊能(Jun-Neng Roan)
11:06 Q & A
11:16 Break
Session III. 兒童心臟血管科
Chair: 吳美環(Mei-Hwan Wu)
11:24 Presentation ........................................................................................ 徐仲豪
(Jong-Hau Hsu)
11:54 與談人: 王主科(Jou-Kou Wang)、吳俊明(Jing-Ming Wu)、
陳銘仁(Ming-Ren Chen)、吳俊仁(Jiunn-Ren Wu)、
楊明浚(Ming-Chun Yang)、黃建富(Chien-Fu Huang)、
詹聖霖(Sheng-Ling Jan)
12:14 Q & A
12:24 Closing Remarks ................................................................................. 吳懿哲
(Yih-Jer Wu)
Page 9
8
12月18日〈星期六〉14:00-15:35 SATURDAY, DECEMBER 18, 2021
Channel 1
TSOC CCS GUIDELINES (I) : DIAGNOSIS
14:00 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 江晨恩(Chern-En Chiang)
14:05 Overview of 2022 Taiwan CCS Guidelines ......................................... 翁國昌
(Kwo-Chang Ueng)
Chair: 簡國龍(Kuo-Liong Chien)
14:20 Assessment Risk/Severity in Patients with Suspected CCS
(CCCC point-based LDL-C Prediction Model) ......................................... 林鴻儒
(Hung-Ju Lin)
Chair: 顏學偉(Hsueh-Wei Yen)
14:35 Screening for Asymptomatic Subjects: When, How, and Why ? ................ 陳志成
(Zhih-Cherng Chen)
Chair: 蔡青峰(Chin-Feng Tsai)
14:50 CCTA vs Stress Diagnostic Modalities
(TET/stress echo/SPECT/CMR/PET): Which One to Choose? ................. 吳彥雯
(Yen-Wen Wu)
Chair: 陳清埤(Ching-Pei Chen)
15:05 Subclinical Subjects with Coronary Stenosis < 50% or high CAC:
How and When to Treat? ...................................................................... 劉尊睿
(Tsun-Jui Liu)
Chairs: 翁國昌(Kwo-Chang Ueng、江晨恩(Chern-En Chiang)
15:20 Panel Discussion
Page 10
9
12月18日〈星期六〉16:00-17:30 SATURDAY, DECEMBER 18, 2021
Channel 1
TSOC CCS GUIDELINES (II) : MANAGEMENT
Chair: 葉宏一(Hung-I Yeh)
16:00 LDL-C Target and Pharmacological Treatment ........................................ 李貽恒
(Yi-Heng Li)
Chair: 林宗憲(Tsung-Hsien Lin)
16:10 Diabetes Management: HbA1c Target and Pharmacological Treatment ..... 江晨恩
(Chern-En Chiang)
Chair: 褚柏顯(Pao-Hsien Chu)
16:20 Anti-thrombotic Drugs ........................................................................... 蘇峻弘
(Chun-Hung Su)
Chair: 黃偉春(Wei-Chun Huang)
16:35 Anti-ischemic Drugs ............................................................................. 郭風裕
(Feng-Yu Kuo)
Chair: 謝宜璋(I-Chang Hsieh)
16:50 Revascularization versus OMT .............................................................. 趙庭興
(Ting-Hsing Chao)
Chair: 殷偉賢(Wei-Hsian Yin)
17:05 PCI: When to Intervene ? ..................................................................... 任勗龍
(Hsu-Lung Jen)
Chairs: 翁國昌(Kwo-Chang Ueng、江晨恩(Chern-En Chiang)
17:15 Panel Discussion
Page 11
10
12月18日〈星期六〉14:00-15:35 SATURDAY, DECEMBER 18, 2021
Channel 2
UPDATE ON AF MANAGEMENT & THERAPY
14:00 Opening Remarks ................................................................................ 陳適安
(Shih-Ann Chen)
Chair: 林彥璋(Yenn-Jiang Lin)
14:03 Clinical Update for AF Screening ........................................................... 趙子凡
(Tze-Fan Chao)
Chair: 王俊傑(Chun-Chieh Wang)
14:15 Who, When and How to Intervene for Subclinical AF ............................... 沃宏達
(Hung-Ta Wo)
Chair: 郭任遠(Jen-Yuan Kuo)
14:27 The Use of AI for AF Detection .............................................................. 林廷澤
(Ting-Tse Lin)
14:39 Chairs: 柯文欽(Wen-Chin Ko)、曹玄明(Hsuan-Ming Tsao)、
黃靜惠(Ching-Hui Huang)
Panel Discussion
Chair: 林亮宇(Lian-Yu Lin)
14:45 Zero-fluoroscopy Catheter Ablation of AF: A Preliminary Report ............... 莊傑貿
(Chieh-Mao Chuang)
Chair: 林維祥(Wei-Shiang Lin)
14:57 New Developments in AF Ablation: HPSD .............................................. 江承鴻
(Cheng-Hung Chiang)
Chair: 賴文德(Wen-Ter Lai)
15:09 New Technology in AF Ablation: Pulsed Field Ablation ............................ 卓士傑
(Shih-Jie Jhuo)
Chairs: 張盛雄(Sheng-Hsiung Chang)、蔡適吉(Su-Kiat Chua)、
羅力瑋(Li-Wei Lo)
15:21 Panel Discussion
15:27 Closing Remarks ................................................................................. 溫明賢
(Ming-Shien Wen)
Page 12
11
12月18日〈星期六〉16:00-17:30 SATURDAY, DECEMBER 18, 2021
Channel 2
ADVANCE ON CARDIAC PACING
16:00 Opening Remarks ............................................................................. . 溫明賢
(Ming-Shien Wen)
Chair: 蔡青峰(Chin-Feng Tsai)
16:03 Leadless Pacemakers for AV Synchrony ................................................ 莊曜聰
(Yao-Tsung Chuang)
Chair: 葉冠宏(Kuan-Hung Yeh)
16:15 Update on Subcutaneous ICD ............................................................... 廖若男
(Jo-Nan Liao)
Chair: 張坤正(Kuan-Cheng Chang)
16:27 Update on His Bundle Pacing ................................................................ 吳宏彬
(Hung-Pin Wu)
16:39 Chairs: 劉言彬(Yen-Bin Liu)、蕭相江(Hsiang-Chiang Hsiao)、
鄭成泉(Chen-Chuan Cheng)
Panel Discussion
Chair: 陳勉成(Mien-Cheng Chen)
16:45 Update on Left Bundle Branch Area Pacing ............................................ 陳煌中
(Huang-Chung Chen)
Chair: 謝仁哲(Jen-Che Hsieh)
16:57 New Indications for CRT in Heart Failure ................................................ 林圀宏
(Kuo-Hung Lin)
Chair: 林立人(Li-Jen Lin)
17:09 Gaps between the Guideline of Cardiac Pacing and Clinical Practice ........ 陳儒逸
(Ju-Yi Chen)
Chairs: 陳永隆(Yung-Lung Chen)、葉勇信(Yung-Hsin Yeh)、
謝育整(Yu-Cheng Hsieh)
17:21 Panel Discussion
17:27 Closing Remarks ................................................................................. 陳文鍾
(Wen-Jone Chen)
Page 13
12
12月18日〈星期六〉14:00-15:30 SATURDAY, DECEMBER 18, 2021
Channel 3
CARDIOVASCULAR SURGERY
以 SYNTAX SCORE 觀點來審視個人對 CAD 治療的經驗
Chair: 蔡建松(Chien-Sung Tsai)
14:00 Cardiovascular Surgery Clinical Outcomes following Heart Team Revascularization
Recommendations in Complex Coronary Artery Disease ....................... 殷偉賢
(Wei-Hsian Yin)
Chair: 張忠毅(Chung-Yi Chang)
14:18 Surgical Challenges of Myocardial Revascularization in Patients with
High SYNTAX Score .............................................................................. 陽厚生
(Hou-Sheng Yang)
Chair: 邱冠明(Kuan-Ming Chiu)
14:36 Early Outcomes With PCI in Complex Patients Unsuited to Surgery…. ... 黃慶昌
(Ching-Chang Huang)
Chair: 陳益祥(Yih-Sharng Chen)
14:54 Operative Strategy for complex patients undergoing CABG. ........................ 王植賢
(Chih-Hsien Wang)
Chairs: 施俊哲(Chun-Che Shih)、阮俊能(Jun-Neng Roan)、
張仁平(Jen-Ping Chang)、陳懷民(Huai-Min Chen)、
鄭伯智(Bor-Chih Cheng)
15:12 Panel Discussion
Page 14
13
12月18日〈星期六〉16:00-17:30 SATURDAY, DECEMBER 18, 2021
Channel 3
JOINT SESSION ON PEDIATRIC AND CV SURGERY 未來台灣小兒心臟內科及外科的走向
Chairs: 張重義(Chung-I Chang)、王主科(Jou-Kou Wang)
16:00 Training for Pediatric Cardiac Surgeon ................................................... 黃書健
(Shu-Chien Huang)
16:15 年輕醫師如何踏入小兒心臟外科的領域,一個半成品的心路歷程,焦
慮,與期待…………………………………………………………….徐綱宏
(Kang-Hong Hsu)
16:30 南臺灣兒心外科現況與未來 .......................................................... 潘俊彥
(Jun-Yen Pan)
16:45 What Will Pediatric Cardiology Look Like in Taiwan by 2040 ? ............... 陳俊安
(Chun-An Chen)
17:00 A New Vision for the Future of Pediatric
Cardiology in Taiwan — My Opinion .................................................. 詹聖霖
(Sheng-Ling Jan)
17:15 Career Development for Future Pediatric Cardiologists: My Personal View
未來兒童心臟科醫師的生涯發展: 我的個人看法………………王玠能
(Jieh-Neng Wang)
Page 15
14
12月18日〈星期六〉14:00-15:30 SATURDAY, DECEMBER 18, 2021
Channel 4
SYMPOSIUM ON BASIC SCIENCE
善用新興工具跨越研究障礙
14:00 Opening Remarks ................................................................................ 劉秉彥
(Ping-Yen Liu)
Chair: 蔡佳醍(Chia-Ti Tsai)
14:05 Next Generation Sequencing for Cardiovascular Diseases Research —
成大醫院經驗分享 .......................................................................... 劉嚴文
(Yen-Wen Liu)
Chair: 陳偉踐(Wei-Jan Chen)
14:30 Milliplex Biomaker Detection Assays in Cardiovascular Disease
Research………… ............................................................................... 呂信邦
(Hsin-Bang Leu)
Chair: 徐國基(Kou-Gi Shyu)
14:55 Protein Array: Application of Protein Array
Analysis in Cardiovascular Research .......................................................... 王士維
(Shih-Wei Wang)
Chair: 葉宏一(Hung-I Yeh)
15:20 Panel Discussion
15:25 Closing Remarks ................................................................................. 葉宏一
(Hung-I Yeh)
Page 16
15
12月18日〈星期六〉16:00-17:30 SATURDAY, DECEMBER 18, 2021
Channel 4
MOST*-TSOC JOINT SYMPOSIUM
跨領域研究方法觀摩坊
16:00 Opening Remarks ................................................................................ 蔡佳醍
(Chia-Ti Tsai)
Chair: 高嘉宏(Jia-Horng Kao)
16:05 肝臟疾病研究模式與實例 .............................................................. 楊宏志
(Hung-Chih Yang)
Chair: 蔡佳醍(Chia-Ti Tsai)
16:25 心血管疾病研究模式與實例 .......................................................... 林錦生
(Chin-Sheng Lin)
Chair: 林宙晴(Chou-Ching Lin)
16:45 神經疾病研究模式與實例 .............................................................. 謝松蒼
(Sung-Tsang Hsieh)
Chair: 劉秉彥(Ping-Yen Liu)
17:05 Panel Discussion
17:25 Closing Remarks ................................................................................. 葉宏一
(Hung-I Yeh)
*Ministry of Science and Technology
Page 17
16
12月19日〈星期日〉09:00-10:30 SUNDAY, DECEMBER 19, 2021
Channel 1
SGLT2 INHIBITOR – A MAGIC BULLET WITH MYSTERIOUS
MECHANISM
09:00 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 侯嘉殷(Charles Jia-Yin Hou)
09:05 SGLT2 Inhibitors HFpEF Data: From Context to Clinical Pearls .......... Javed Butler
Chairs: 李啟明(Chii-Ming Lee)、王兆弘(Chao-Hung Wang)
09:35 SGLT2i --- An OHA Reversed from Safety
Concern to Favorable CV Outcome……………………. ............................ 洪崇烈
(Chung-Lieh Hung)
10:00 Efficacy and Potential Mechanisms of SGLT2i on Renal Function in
Patients with Heart Failure .................................................................... 徐莞曾
(Wan-Tseng Hsu)
10:25 Closing Remarks ................................................................................. 李啟明
(Chii-Ming Lee)
Page 18
17
12月19日〈星期日〉11:00-12:30 SUMDAY, DECEMBER 19, 2021
Channel 1
ELECTROPHYSIOLOGY INTERVENTION IN ADVANCED HEART
FAILURE
Chairs: 溫明賢(Ming-Shien Wen)、林亮宇(Lian-Yu Lin)
11:00 Atrial Fibrillation in Advanced HF-- Ablation or Not? ................................. 謝育整
(Yu-Cheng Hsieh)
11:30 Intervention of Life Threating VT in Advanced HF .................................... 林彥璋
(Yenn-Jiang Lin)
12:00 Left Bundle Branch Pacing -- The Panacea for
Ventricular Pacing in HFrEF?...................... ........................................... 王俊傑
(Chun-Chieh Wang)
Page 19
18
12月19日〈星期日〉09 :00-10 :30 SUNDAY, DECEMBER19, 2021
Channel 2
INTERVENTIONAL CARDIOLOGY – MASTER’S MOST MEMORABLE CASE IN 2021
09:00 Opening Remarks ................................................................................ 王志鴻
(Ji-Hung Wang)
Chair: 陳清埤(Ching-Pei Chen)
09:05 My Most Memorable Case in 2021 ......................................................... 王志鴻
(Ji-Hung Wang)
09:20 Q & A
Chair: 張其任(Chi-Jen Chang)
09:25 My Most Memorable Case in 2021 ......................................................... 吳炯仁
(Chiung-Jen Wu)
09:40 Q & A
Chair: 陳志成(Zhih-Cherng Chen)
09:45 My Most Memorable Case in 2021 ......................................................... 李文領
(Wen-Lieng Lee)
10:00 Q & A
Chair: 曹殿萍(Tien-Ping Tsao)
10:05 My Most Memorable Case in 2021 ......................................................... 高憲立
(Hsien-Li Kao)
10:20 Q & A
10:25 Closing Remarks ................................................................................. 曹殿萍
(Tien-Ping Tsao)
Panelists: 蔡政廷(Cheng-Ting Tsai)、郭風裕(Feng-Yu Kuo)、
盧澤民(Tse-Min Lu)
Page 20
19
12月19日〈星期日〉11 :00-12 :30 SUNDAY, DECEMBER19, 2021
Channel 2
INTERVENTIONAL CARDIOLOGY –
PERIPHERAL INTERVENTION
11:00 Opening Remarks ................................................................................ 黃玄禮
(Hsuan-Li Huang)
Which Revascularization Techniques Should be the
First Choice in Acute Limb Ischemia ?
Chair: 黃玄禮(Hsuan-Li Huang)
11:05 Endovascular Revascularization ............................................................ 許栢超
(Po-Chao Hsu)
11:25 Surgical Revascularization .................................................................... 溫日昇
(Jih-Sheng Wen)
Routine Early Catheter-directed Thrombolysis for Submassive Pulmonary
Embolism
Chair: 徐中和(Chung-Ho Hsu)
11:45 Pros .................................................................................................... 李任光
(Jen-Kuang Lee)
12:05 Cons ................................................................................................... 張獻元
(Hsien-Yuan Chang)
12:25 Closing Remarks ................................................................................. 徐中和
(Chung-Ho Hsu)
Page 21
20
12月19日〈星期日〉09 :00-10 :30 SUNDAY, DECEMBER19, 2021
Channel 3
SYMPOSIUM ON CARDIAC IMAGING
CLINICAL APPLICATION OF STRESS ECHO
Chairs:梁馨月(Hsin-Yueh Liang)、謝培欽(Bill Pei-Chin Hsieh)
09:00 Small Aortic Valvular Area, True AS or Pseudo AS? .............................. 呂岱穎
(Dai-Yin Lu)
09:20 Coronary Artery Disease, only TET or Tl201? ....................................... 陳美綾
(Mei-Ling Chen)
09:40 Poor LV Function, transplantation or repeated revascularization? .......... 張瑋婷
(Wei-Ting Chang)
10:00 Exertional Dyspnea, but Preserved LVEF ............................................. 董承昌
(Cheng-Chang Tung)
10:20 Panel Discussion
Page 22
21
12月19日〈星期日〉11 :00-12 :30 SUNDAY, DECEMBER19, 2021
Channel 3
SYMPOSIUM ON CARDIAC IMAGING
PEARLS AND PITFALLS IN IMAGING COMPLEX VALVULAR
HEART DISEASE
Chairs:余文鍾(Wen-Chung Yu)、林隆君(Jiun-Yi Li)
11:00 Echocardiography in Diagnosis of Valvular Heart Disease of Prosthetic Valves
………………………………………………………………………………………李廣祚
(Kuang-Tso Lee)
11:20 Combined and Multiple-Valve Diseases.................................................. 李慶威
(Ching-Wei Lee)
11:40 Adults with Congenital Heart Disease: Focus on the Right-Sided Valves ... 陳俊安
(Chun-An Chen)
12:00 Isolated Tricuspid Regurgitation ............................................................. 黃冠智
(Kuan-Chih Huang)
12:20 Panel Discussion
Page 23
22
12月19日〈星期日〉09 :00-10 :30 SUNDAY, DECEMBER19, 2021
Channel 4
UPDATED REPORT OF THE TAIPAN REGISTRY
09:00 Opening Remarks ................................................................................ 黃偉春
(Wei-Chun Huang)
Chair: 賀萬靖(Wan-Jing Ho)
09:05 TAIPANS Registry 1 Year Report ........................................................... 劉維新
(Wei-Shin Liu)
Chair: 邱昱偉(Yu-Wei Chiu)
09:20 Age Effect in PAH Patient Care ............................................................. 鄭錦昌
(Chin-Chang Cheng)
Chair: 吳懿哲(Yih-Jer Wu)
09:35 Uric Acid as A Biomarker in Distinct Groups of Pulmonary Hypertension ... 吳書豪
(Shu-Hao Wu)
Chair: 林彥宏(Yen-Hung Lin)
09:50 CTD-PAH in Taiwan .............................................................................. 張捷宇
(Chieh-Yu Chang)
Chair: 朱俊源(Chun-Yuan Chu)
10:05 Renal Function and PH ......................................................................... 賴志泓
(Chih-Hung Lai)
Chair: 許志新(Chih-Hsin Hsu)
10:20 Panel Discussion
10:25 Closing Remarks ................................................................................. 趙庭興
(Ting-Hsing Chao)
Page 24
23
12月19日〈星期日〉11 :00-12 :30 SUNDAY, DECEMBER19, 2021
Channel 4
SYMPOSIUM ON 2021 TSOC/TSH* HYPERTENSION GUIDELINE
11:00 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 鄭景仁(Jing-Ren Jeng)
11:05 Definition and Classification of Hypertension .......................................... 江晨恩
(Chern-En Chiang)
Chair: 梁興禮(Hsin-Li Liang)
11:20 Diagnosis including Optimal Method to Measure BP in Patients with AF, Out-of-office
BP (HBPM and ABPM) & Central Aortic Pressure.................................... 鄭浩民
(Hao-Min Cheng)
Chair: 吳文憲(Wen-Shiann Wu)
11:35 Blood Pressure Targets......................................................................... 林宗憲
(Tsung-Hsien Lin)
Chair: 黃靜惠(Ching-Hui Huang)
11:50 Drug Therapy ....................................................................................... 王宗道
(Tzung-Dau Wang)
Chair: 蔡惟全(Wei-Chuan Tsai)
12:05 Panel Discussion
12:25 Closing Remarks ................................................................................. 洪惠風
(Huei-Fong Hung)
* Taiwan Hypertension Society
Page 25
24
12月18日〈星期六〉12:40-14:00 SATURDAY, DECEMBER 18, 2021
Channel 1
LUNCHEON SYMPOSIUM:
COMPREHENSIVE PROTECTION ACROSS CARDIORENAL
CONTINUUM: TWO FACES OF THE SAME COIN
-THE CROSSTALK BETWEEN CARDIOLOGIST AND
NEPHROLOGIST
(AstraZeneca)
12:40 Opening Remarks ................................................................................ 葉森洲
(San-Jou Yeh)
Chair: 葉森洲(San-Jou Yeh)
12:45 How to Manage Cardio-Renal Interplay ?
From Cardiologist’s Perspective ............................................................ 江晨恩
(Chern-En Chiang)
Chair: 許惠恒(Wayne Huey-Herng Sheu)
13:15 How to Manage Cardio-Renal Interplay ?
From Nephrologist’s Perspective ........................................................... 吳明儒
(Ming-Ju Wu)
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 許惠恒
(Wayne Huey-Herng Sheu)
Page 26
25
12月18日〈星期六〉12:40-14:00 SATURDAY, DECEMBER 18, 2021
Channel 2
LUNCHEON SYMPOSIUM:
BROADEN HEART PROTECTION
(Boehringer-Ingelheim)
12:40 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 侯嘉殷(Charles Jia-Yin Hou)
12:45 Start from EMPA-REG OUTCOME:
Paradigm Shift in Diabetes Care ............................................................ 林宗憲
(Tsung-Hsien Lin)
Chair: 李啟明(Chii-Ming Lee)
13:15 Rise of EMPEROR: Latest Update from SGLT2i in Heart Failure .............. 王俊傑
(Chun-Chieh Wang)
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 李啟明
(Chii-Ming Lee)
Page 27
26
12月18日〈星期六〉12:40-14:00 SATURDAY, DECEMBER 18, 2021
Channel 3
LUNCHEON SYMPOSIUM:
FROM SPAF TO VTE- ANTITHROMBOTIC THERAPY
OPTIMIZATION
(Daiichi Sankyo)
12:40 Opening Remarks ................................................................................ 詹貴川
(Kuei-Chuan Chan)
Chair: 詹貴川(Kuei-Chuan Chan)
12:45 Optimize NOAC Dosage for SPAF-Deep Dive into 4 NOACs RCT ............ 趙子凡
(Tze-Fan Chao)
Chair: 黃玄禮(Hsuan-Li Huang)
13:15 Optimizing Outcomes in Treatment for Venous Thromboembolism ........... 吳家棟
(Chia-Tung Wu)
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 黃玄禮
(Hsuan-Li Huang)
Page 28
27
12月18日〈星期六〉12:40-14:00 SATURDAY, DECEMBER 18, 2021
Channel 4
LUNCHEON SYMPOSIUM:
EMERGING STRATEGY FOR HFREF TREATMENT:
DATA, GUIDELINES, AND APPLICATIONS
(Bayer)
12:40 Opening Remarks ................................................................................ 趙庭興
(Ting-Hsing Chao)
Chair: 趙庭興(Ting-Hsing Chao)
12:45 The Role of Vericiguat in Patients with Heart Failure:
An Overview of VICTORIA and Case Sharing ......................................... 劉銘恩
(Ming-En Liu)
13:10 Q&A
Chair: 陳文鍾(Wen-Jone Chen)
13:20 Learnings from the Past: Strategies for Stroke Prevention in
Elderly AF Patients ............................................................................... 徐千彝
(Chien-Yi Hsu)
13:45 Q&A
13:55 Closing Remarks ................................................................................. 陳文鍾
(Wen-Jone Chen)
Page 29
28
12月18日〈星期六〉17:40-19:00 SATURDAY, DECEMBER 18, 2021
Channel 1
EVENING SYMPOSIUM:
HOW DO YOU PROVIDE HIGH QUALITY OF HF MANAGEMENT
AND WHAT CAN YOU DO MORE FOR HF PATIENTS
(Novartis)
17:40 Opening Remarks ................................................................................ 侯嘉殷
(Charles Jia-Yin Hou)
Chair: 侯嘉殷(Charles Jia-Yin Hou)
17:45 From Theory to Real World: How do you Provide the
High Quality of HF Management? ......................................................... 李貽恒
(Yi-Heng Li)
Chair: 趙庭興(Ting-Hsing Chao)
18:15 From Late Treatment to Early Treatment:
What Can You Do More for HF Patients? .............................................. 張鴻猷
(Hung-Yu Chang)
18:45 Panel Discussion .......................................................................................... All
18:55 Closing Remarks ................................................................................. 趙庭興
(Ting-Hsing Chao)
Page 30
29
12月18日〈星期六〉17:40-19:00 SATURDAY, DECEMBER 18, 2021
Channel 2
EVENING SYMPOSIUM:
LATEST GUIDELINE IMPLICATION ON AF PATIENTS CARE
(Pfizer)
17:40 Opening Remarks ................................................................................ 朱志生
(Chih-Sheng Chu)
Chair: 朱志生(Chih-Sheng Chu)
17:45 What is New on APHRS AF Guideline? ................................................. 詹益欣
(Yi-Hsin Chan)
Chair: 黃世忠(Shih-Chung Huang)
18:15 Case Discussion: Managing Challenging AF Patients ............................ 李俊偉
(Chun-Wei Lee)
18:45 Panel Discussion .......................................................................................... All
18:55 Closing Remarks ................................................................................. 黃世忠
(Shih-Chung Huang)
Page 31
30
12月18日〈星期六〉17:40-19:00 SATURDAY, DECEMBER 18, 2021
Channel 3
EVENING SYMPOSIUM:
FABRY DISEASE: SYMPTOMS, DIAGNOSIS, AND TREATMENT
(Takeda)
17:40 Opening Remarks ................................................................................ 余文鍾
(Wen-Chung Yu)
Chair: 余文鍾(Wen-Chung Yu)
17:45 New Insights in Pathophysiology of Cardiac Damage in
Fabry Disease ................................................................................ Ales Linhart
(Czech)
Chair: 黃偉春(Wei-Chun Huang)
18:15 Clinical Case Sharing .......................................................................... 林志展
(Chih-Chan Lin)
18:45 Panel Discussion .......................................................................................... All
18:55 Closing Remarks ................................................................................. 黃偉春
(Wei-Chun Huang)
Page 32
31
12月18日〈星期六〉17:40-19:00 SATURDAY, DECEMBER 18, 2021
Channel 4
EVENING SYMPOSIUM:
ROLE OF GLP-1RAS IN LOWERING ASCVD RISK IN TYPE 2
DIABETES
(Novo Nordisk)
17:40 Opening Remarks ................................................................................ 吳彥雯
(Yen-Wen Wu)
Chair: 吳彥雯(Yen-Wen Wu)
17:45 Exploring the Latest Evidence of CV Benefits with GLP-1RAs ................ 林柏霖
(Po-Lin Lin)
18:15 GLP-1 RA Benefits Extend Beyond MACE Reduction in T2D
Patients from Taiwan Cohor Study ........................................................ 李任光
(Jen-Kuang Lee)
18:45 Panel Discussion .......................................................................................... All
18:55 Closing Remarks ................................................................................. 吳彥雯
(Yen-Wen Wu)
Page 33
32
12月19日〈星期日〉12:40-14:00 SUNDAY, DECEMBER 19, 2021
Channel 1
LUNCHEON SYMPOSIUM:
A PROMISING NEW ERA IN THE MANAGEMENT OF ATTR-CM
(Pfizer)
12:40 Opening Remarks ................................................................................ 張坤正
(Kuan-Cheng Chang)
Chair: 張坤正(Kuan-Cheng Chang)
12:45 Achieving Non-invasive Diagnosis of ATTR-CM ...................................... 林志展
(Chih-Chan Lin)
Chair: 陳震寰(Chen-Huan Chen)
13:15 Early Diagnosis and Treatment of ATTR-CM:
Why Is It So Important? ........................................................................ 林彥宏
(Yen-Hung Lin)
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 陳震寰
(Chen-Huan Chen)
Page 34
33
12月19日〈星期日〉12:40-14:00 SUNDAY, DECEMBER 19, 2021
Channel 2
LUNCHEON SYMPOSIUM:
JUMP! INTO A NEW ERA OF LIPID MANAGEMENT
(Organon)
12:40 Opening Remarks ................................................................................ 江晨恩
(Chern-En Chiang)
Chair: 江晨恩(Chern-En Chiang)
12:45 Targeting LDL- C!. ................................................................................ 陳宗瀛
(Chung-Yin Chen)
13:35 Discussion
13:55 Closing Remarks ................................................................................. 江晨恩
(Chern-En Chiang)
Page 35
34
12月19日〈星期日〉12:40-14:00 SUNDAY, DECEMBER 19, 2021
Channel 3
LUNCHEON SYMPOSIUM:
BETA BLOCKER ROLE IN HYPERTENSION TREATMENT
(Menarini)
12:40 Opening Remarks ................................................................................ 葉宏一
(Hung-I Yeh)
Chair: 葉宏一(Hung-I Yeh)
12:45 What Can We Do Better for HTN and HTN-HF Patients? ......................... 林宗憲
(Tsung-Hsien Lin)
13:15 Should We Treat Men and Women Differently?
The Relationship Between Gender and Hypertension .................................... TBD
( )
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 葉宏一
(Hung-I Yeh)
Page 36
35
12月19日〈星期日〉12:40-14:00 SUNDAY, DECEMBER 19, 2021
Channel 1
LUNCHEON SYMPOSIUM:
SAVE MORE LIVES AND ORGAN PROTECTION:
FROM ACS TO CRS (CARDIORENAL SYNDROME)
(AstraZeneca)
12:40 Opening Remarks ................................................................................ 陳志成
(Zhih-Cherng Chen)
Chair: 陳志成(Zhih-Cherng Chen)
12:45 Short and Long Oral Antiplatelet Therapy in Acute Coronary Syndromes:
State of the Art ..................................................................................... 曹承榮
(Chen-Rong Tsao)
Chair: 李貽恒(Yi-Heng Li)
13:15 The Diabetes-kidney-heart Failure Continuum: One Tablet Fits All ........ 吳彥雯
(Yen-Wen Wu)
13:45 Panel Discussion
13:55 Closing Remarks ................................................................................. 李貽恒
(Yi-Heng Li)